Related Experiment Video

Updated: Aug 1, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Expression of Bcl-2 family of proteins in fresh myeloma cells

N Harada1, H Hata, M Yoshida

  • 1Second Department of Internal Medicine, Kumamoto University School of Medicine, Honjo, Japan.

Leukemia
|November 21, 1998
PubMed

Insights

Bcl-2 family proteins, including Bcl-2 and Bcl-X(L), show varied expression in multiple myeloma (MM) and plasma cell leukemia (PCL). Bcl-2 correlates with early MM stages, while Bcl-X(L) may indicate advanced disease and extramedullary invasion.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Hematology

Background:

  • The Bcl-2 protein family regulates apoptosis and drug resistance.
  • Understanding Bcl-2 family protein expression is crucial for myeloma treatment.
  • Key members include Bcl-2, Bcl-X(L), Bcl-Xs, and Bax.

Purpose of the Study:

  • To analyze the expression of Bcl-2 family proteins in fresh human myeloma cells.
  • To correlate protein expression with clinical staging and disease characteristics.
  • To investigate the role of these proteins in drug sensitivity and patient prognosis.

Main Methods:

  • Western blotting was used to detect Bcl-2 family protein expression.
  • Seventeen multiple myeloma (MM) and three plasma cell leukemia (PCL) cases were analyzed.
  • Expression levels were correlated with clinical stage, extramedullary lesions, chemotherapy history, and survival data.

Main Results:

  • Bcl-2 and Bcl-X(L) were detected in 12 and 9 samples, respectively.
  • All PCL cases co-expressed Bcl-2 and Bcl-X(L).
  • Bcl-2 expression was higher in early-stage MM, while Bcl-X(L) was associated with advanced stages and extramedullary lesions.
  • Bax expression was notably absent in most cases.
  • No significant correlation was found between Bcl-2/Bcl-X(L) expression and prior chemotherapy.
  • Bcl-X(L) expression showed a trend towards association with poor prognosis.

Conclusions:

  • Bcl-2 family protein expression is heterogeneous in myeloma cells.
  • Bcl-X(L) and Bcl-2 expression may be linked to extramedullary invasion and early disease stages, respectively.
  • The absence of Bax might contribute to reduced sensitivity to certain anti-cancer drugs in myeloma.

More Related Videos

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...